They have been leaders in clinical pharmacy for many years and have been involved in several profession-wide initiatives, influencing practice all over the UK and internationally.
The UKCPA Cardiovascular Group develops and delivers regular UKCPA learning events in cardiovascular subjects.Alongside other RPS Affiliated Partners, the UKCPA Cardiovascular Group were instrumental in pioneering the development of professional development frameworks and tools which have since been adapted to become the basis of the Royal Pharmaceutical Society Foundation and Faculty programmes.
The Group were also one of the first to develop professional curricula which defines the knowledge, skills, behaviours and experiences that constitute advanced and expert practice, and contributed, along with other RPS Affiliated Partners, in developing the professional recognition process which has informed the basis of the Royal Pharmaceutical Society Faculty [hyperlink to https://www.rpharms.com/professional-development/faculty]
In 2013, the Group launched a report calling for action from healthcare leaders across the UK, to support the development of a clear patient pathway to improve the diagnosis and management of atrial fibrillation (AF). The report set out an ideal patient pathway, which supports increased diagnosis of patients with AF, appropriate prescription of anticoagulation therapies for patients at risk of stroke, and effective management of these patients through follow up.
If you would like to know more about the Cardiovascular Group, or its subgroups of HAT, Heart Failure or Stroke, or would like to get involved in their activities, please contact the Chair, Helen Williams, on email@example.com
Joining UKCPA is easy with a range of payment options to suit you. Join today and start enjoying the benefits immediately.